Issue Date: April 6, 2015
α/β-Peptides Could Offer Low-Cost Alternative To Antibody Drugs
A peptide scaffold made partly of nonnatural β-amino acids could serve as a versatile source of potential drugs that bind large proteins such as the anticancer target VEGF, researchers report. The nonnatural peptides offer a possibly advantageous alternative to antibody-based agents that target large proteins because the peptides are easier to make and may last longer in the body.
To modulate the activity of proteins such as VEGF, drugmakers must block their interactions with other . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society